Immune responses from early study of novel sarcoma vaccine

(Fred Hutchinson Cancer Research Center) The critical component of an experimental vaccine led to an escalating immune response in patients with sarcoma, an indicator of its potential anti-cancer effects.This is according to a poster to be presented June 5 at the American Society of Clinical Oncology annual meeting in Chicago.